Aurobindo Pharma gets tentative FDA approval for generic HIV treatment for children
Aurobindo Pharma Limited has achieved a significant milestone by securing the US Food and Drug Administration (FDA)'s tentative nod under the PEPFAR program for its ... Read More
Aurobindo Pharma subsidiary receives FDA approval for Plerixafor Injection
Eugia Pharma Specialities Limited, a fully-owned subsidiary of India-based Aurobindo Pharma Limited, has received final approval from the US Food and Drug Administration (FDA). This ... Read More
Aurobindo Pharma achieves promising results for breast cancer biosimilar in Phase 3 trial
Aurobindo Pharma has announced positive results from a Phase 3 clinical trial of its breast cancer biosimilar product, BP02 (Trastuzumab or biosimilar to Herceptin), developed ... Read More
Aurobindo subsidiary gets license to develop and market Nilotinib Capsules in LMICs
Aurobindo Pharma, along with its subsidiary Eugia Pharma Specialities has announced a voluntary sub-licensing agreement with Medicines Patent Pool (MPP) to develop and market Nilotinib ... Read More
Aurobindo Pharma announces FDA final approval for Amphotericin B Liposome for Injection
Aurobindo Pharma said that its fully-owned subsidiary — Eugia Pharma Specialities has secured final approval for Amphotericin B Liposome for Injection, 50 mg from the ... Read More
Aurobindo Pharma oral manufacturing facility gets FDA establishment inspection report
Aurobindo Pharma has been issued an establishment inspection report (EIR) from the US Food and Drug Administration (FDA) for one of its manufacturing facilities in ... Read More
Aurobindo Pharma gets DCGI nod for Molnupiravir generic version
Aurobindo Pharma has secured consent from the Drugs Controller General of India (DCGI) for manufacturing and distributing its generic version of Covid drug Molnupiravir under ... Read More
Aurobindo subsidiary Eugia gets FDA approval for Cyclophosphamide Injection
Aurobindo Pharma said that its subsidiary Eugia Pharma Specialities has secured approval from the US Food and Drug Administration (FDA) for the new drug application ... Read More
Aurobindo Pharma scraps Rs 420cr stake deal with Cronus Pharma
Aurobindo Pharma Limited has scrapped its previously signed binding agreements with Cronus Pharma Specialities India Private Limited, under which it was to acquire a stake ... Read More
Spectrum Pharmaceuticals to divest seven oncology drugs in $300m deal with Acrotech Biopharma
In a major strategic move, Spectrum Pharmaceuticals, a prominent US-based biopharma company, has entered into a deal with Acrotech Biopharma, a subsidiary of Aurobindo Pharma ... Read More